Proactive Drug Monitoring Improves Outcomes in Kids With Crohn ’ s Proactive Drug Monitoring Improves Outcomes in Kids With Crohn ’ s

Proactive therapeutic-drug monitoring (TDM) in children with Crohn ' s disease on adalimumab reduces clinical exacerbations compared to reactive TDM, a randomized controlled trial shows.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news